111 related articles for article (PubMed ID: 27895579)
1. Pharmacodynamic Modeling of Cell Cycle Effects for Gemcitabine and Trabectedin Combinations in Pancreatic Cancer Cells.
Miao X; Koch G; Ait-Oudhia S; Straubinger RM; Jusko WJ
Front Pharmacol; 2016; 7():421. PubMed ID: 27895579
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic modeling of combined chemotherapeutic effects predicts synergistic activity of gemcitabine and trabectedin in pancreatic cancer cells.
Miao X; Koch G; Straubinger RM; Jusko WJ
Cancer Chemother Pharmacol; 2016 Jan; 77(1):181-93. PubMed ID: 26604207
[TBL] [Abstract][Full Text] [Related]
3. Systems Pharmacodynamic Model of Combined Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways.
Miao X; Koch G; Shen S; Wang X; Li J; Shen X; Qu J; Straubinger RM; Jusko WJ
J Pharm Sci; 2024 Jan; 113(1):235-245. PubMed ID: 37918792
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells.
Hamed SS; Straubinger RM; Jusko WJ
Cancer Chemother Pharmacol; 2013 Sep; 72(3):553-63. PubMed ID: 23835677
[TBL] [Abstract][Full Text] [Related]
5. Systems pharmacodynamic model of combined gemcitabine and trabectedin in pancreatic cancer cells. Part I.Çô Effects on signal transduction pathways related to tumor growth.
Miao X; Shen S; Koch G; Wang X; Li J; Shen X; Qu J; Straubinger RM; Jusko WJ
J Pharm Sci; 2024 Jan; 113(1):214-227. PubMed ID: 38498417
[TBL] [Abstract][Full Text] [Related]
6. Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells.
Nishikubo K; Ohgaki R; Liu X; Okanishi H; Xu M; Endou H; Kanai Y
Cancer Cell Int; 2023 Jun; 23(1):116. PubMed ID: 37322479
[TBL] [Abstract][Full Text] [Related]
7. Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells.
Acikgoz E; Guven U; Duzagac F; Uslu R; Kara M; Soner BC; Oktem G
PLoS One; 2015; 10(10):e0141090. PubMed ID: 26485709
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel.
Adema AD; Laan AC; Myhren F; Fichtner I; Verheul HM; Sandvold ML; Peters GJ
Int J Oncol; 2010 Jan; 36(1):285-94. PubMed ID: 19956857
[TBL] [Abstract][Full Text] [Related]
9. Antifibrotic Agent Pirfenidone Suppresses Proliferation of Human Pancreatic Cancer Cells by Inducing G0/G1 Cell Cycle Arrest.
Usugi E; Ishii K; Hirokawa Y; Kanayama K; Matsuda C; Uchida K; Shiraishi T; Watanabe M
Pharmacology; 2019; 103(5-6):250-256. PubMed ID: 30731453
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive complex systems approach to the study and analysis of mammalian cell cycle control system in the presence of DNA damage stress.
Abroudi A; Samarasinghe S; Kulasiri D
J Theor Biol; 2017 Sep; 429():204-228. PubMed ID: 28647496
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Effect of Trabectedin and Olaparib Combination Regimen in Breast Cancer Cell Lines.
Ávila-Arroyo S; Nuñez GS; García-Fernández LF; Galmarini CM
J Breast Cancer; 2015 Dec; 18(4):329-38. PubMed ID: 26770239
[TBL] [Abstract][Full Text] [Related]
12. Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models.
Martinez-Cruzado L; Tornin J; Rodriguez A; Santos L; Allonca E; Fernandez-Garcia MT; Astudillo A; Garcia-Pedrero JM; Rodriguez R
Neoplasia; 2017 Jun; 19(6):460-470. PubMed ID: 28494349
[TBL] [Abstract][Full Text] [Related]
13. Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment.
Fetterly GJ; Owen JS; Stuyckens K; Passarell JA; Zannikos P; Soto-Matos A; Izquierdo MA; Perez-Ruixo JJ
Cancer Chemother Pharmacol; 2008 Jun; 62(1):135-47. PubMed ID: 17922277
[TBL] [Abstract][Full Text] [Related]
14. Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas.
Laroche A; Chaire V; Le Loarer F; Algéo MP; Rey C; Tran K; Lucchesi C; Italiano A
J Hematol Oncol; 2017 Apr; 10(1):84. PubMed ID: 28399901
[TBL] [Abstract][Full Text] [Related]
15. PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models.
Pignochino Y; Capozzi F; D'Ambrosio L; Dell'Aglio C; Basiricò M; Canta M; Lorenzato A; Vignolo Lutati F; Aliberti S; Palesandro E; Boccone P; Galizia D; Miano S; Chiabotto G; Napione L; Gammaitoni L; Sangiolo D; Benassi MS; Pasini B; Chiorino G; Aglietta M; Grignani G
Mol Cancer; 2017 Apr; 16(1):86. PubMed ID: 28454547
[TBL] [Abstract][Full Text] [Related]
16. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F
Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repair.
Harnicek D; Kampmann E; Lauber K; Hennel R; Cardoso Martins AS; Guo Y; Belka C; Mörtl S; Gallmeier E; Kanaar R; Mansmann U; Hucl T; Lindner LH; Hiddemann W; Issels RD
Int J Cancer; 2016 Jul; 139(2):467-79. PubMed ID: 26933761
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-fluouracil combined with sulfasalazine on human pancreatic carcinoma cell line BxPC-3 proliferation and apoptosis in vitro.
Huang Z; Guo KJ; Guo RX; He SG
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):312-20. PubMed ID: 17548258
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer benefits from trabectedin combination with the β-blocker propranolol:
Di Fonte R; Strippoli S; Garofoli M; Cormio G; Serratì S; Loizzi V; Fasano R; Arezzo F; Volpicella M; Derakhshani A; Guida M; Porcelli L; Azzariti A
Front Cell Dev Biol; 2023; 11():1178316. PubMed ID: 37384250
[No Abstract] [Full Text] [Related]
20. Apoptosis during HL-60 cell differentiation is closely related to a G0/G1 cell cycle arrest.
Terui Y; Furukawa Y; Kikuchi J; Saito M
J Cell Physiol; 1995 Jul; 164(1):74-84. PubMed ID: 7790399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
